Genmab — Oktober 2018

[Schiff]

Jeg ved ikke hvor det kommer fra, men ser tit at folk henviser til NBI. Jeg ser ingen sammenhæng mellem Genmab og NBI what so ever

[Sukkeralf]

Just a moment...

(www.firstwordpharma.com)

[E_L]

thanks @Sukkeralf webcast and slides here http://ir.horizon-pharma.com/events/event-details/teprotumumab-investor-call

[E_L]

Thyroid Eye Disease (TED) impacts 15,000 to 20,000 U.S patients annually , estimated peak US sales USD750mio

[bikube]

JnJ stiger 0,23% trods "Bred nedgang på Wall Street" og NBI.

[polle1]

God morgen

[Helge_LarsenPI-redaktør]

God morgen.

[JKY_VH]

God morgen. Ser ud til, at du skal til højmesse igen polle

[jkj]

Godmorgen, tror at polle skal have hele familien med denne gang.

[JKY_VH]

[Helge_LarsenPI-redaktør]

Ro på: http://www.proinvestor.com/debat/76307

[transalp]

Go morgen..

[polle1]

@JKY og jkj : samler familie og venner til på søndag

[polle1]

Tak Helge, hvor er Hans Henrik dog i bund og grund fantastisk sympatisk at lytte til, ikke bare i denne video, men helt generelt !

[E_L]

they just have to find a disease reacting like AL amyloidosis that is bigger…
https://twitter.com/OncLiveSOSS/status/1048011102137798656

[E_L]

preferably before the weekend please…

[E_L]

by the way, the royalty rate on Teprotumumab has not been revealed yet, has it?

[mobbyduck1]

i think the word was high single digit

[E_L]

yea, that is the last i remember, ok thks

[E_L]

say 7% at &750mio peak sales could be a nice $50mio p/a, against 0 cost.